Ultromics secures FDA clearance for heart failure AI software

By AuntMinnie.com staff writers

December 6, 2022 -- Ultromics has secured clearance from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-based echocardiography software for the detection of heart failure with preserved ejection fraction (HFpEF).

EchoGo Heart Failure uses AI to identify HFpEF from a single echocardiogram image, according to the firm.

The clearance come just weeks after Ultromics joined the Foundation for the National Institutes of Health Accelerating Medicines Partnership Heart Failure program, which is a collaboration between the National Institutes of Health, the National Heart Lung and Blood Institute, the FDA, the American Heart Association, the American Society of Echocardiography, and industry, the company said.

Copyright © 2022 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking